NCT07256821 Identifying the Optimal IMT Dose in ICU
| NCT ID | NCT07256821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust |
| Condition | Difficult to Wean, Mechanically Ventilated Patients With a Tracheostomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-11-23 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-11-23 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
200,000 adults are admitted to intensive care in the UK each year. Many of these patients need help with their breathing and are put on a machine called a ventilator. Research shows that many patients using a ventilator quickly develop weakness in their main breathing muscle, called the diaphragm. This weakness can cause a longer time on the ventilator, a longer hospital stay, and higher chances of health problems or death. Inspiratory muscle training is a breathing exercise where the patient breathes against resistance through a small device (like breathing through a straw). It aims to improve the strength of the diaphragm and reduce how long patients are on the ventilator. Why is this research needed? Research shows that current breathing exercise programmes do not help patients come off the ventilator or go home quicker. This may be because these breathing exercises strengthen the wrong muscles (those in the chest and neck, that are not efficient). These exercises can also be distressing for patients. What will be done in this research? This research aims to develop a breathing exercise programme that focusses on strengthening the diaphragm. We will also make sure patients do not find the breathing exercise too distressing. This research will measure how the breathing muscles respond to four different levels of breathing exercise and ask patients to feedback on each level. 1. At each breathing exercise level, the effort of the breathing muscles will be measured using a small tube inserted into the nostril and small sticky patches on the chest and neck. We aim to find the level where the diaphragm is being pushed to work hard but other muscles in the chest and neck are not. 2. After each breathing exercise level patients will be asked how they found it - for example, easy, pleasant, scary. This procedure will be repeated 1-3 times over seven days with at least 24 hours between each measurement
Eligibility Criteria
Inclusion Criteria: * Mechanically ventilated patients with a tracheostomy * Aged ≥ 18 years * Co-operative and able to participate in IMT. * Informed consent or surrogate approval Exclusion Criteria: * Facial or skull fracture, or a bleeding disorder which would prohibit oesophageal catheter placement. * Undrained pneumothorax/pneumomediastinum. * Delirium or deep sedation that impedes the patient's ability to participate in study procedures * Pregnancy * Unlikely to survive, or consultant assessment that the patient is not appropriate. * Wounds that prohibit EMG electrode placement.
Frequently Asked Questions
Who can join the NCT07256821 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Difficult to Wean, Mechanically Ventilated Patients With a Tracheostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07256821 currently recruiting?
Yes, NCT07256821 is actively recruiting participants. Visit ClinicalTrials.gov or contact Royal Brompton & Harefield NHS Foundation Trust to inquire about joining.
Where is the NCT07256821 trial being conducted?
This trial is being conducted at Marlow, United Kingdom.
Who is sponsoring the NCT07256821 clinical trial?
NCT07256821 is sponsored by Royal Brompton & Harefield NHS Foundation Trust. The trial plans to enroll 40 participants.